Research ArticleDrug Discovery

Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition

Science Translational Medicine  03 Apr 2013:
Vol. 5, Issue 179, pp. 179ra44
DOI: 10.1126/scitranslmed.3005213

You are currently viewing the pdf extract.

View Full Text
As a service to the community, AAAS/Science has made this article free with registration.

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview